ASPG and extranodal nasal NK/T cell lymphoma: Wang et al. [5] and Lin et al. [4] demonstrated that GELOX (gemcitabine, oxaliplatin, and asparaginase) and CHOPL (cyclophosphamide, adriamycin, vincristine, prednisone, and asparaginase) were well tolerated and had great activity in the treatment of early stage NKTCL.